Welcome to LookChem.com Sign In|Join Free
  • or
4-Cyclohexyl-buten-3-in-1, also known as 4-cyclohexyl-1-buten-3-yne, is an organic compound characterized by a unique structure that combines a cyclohexane ring with a buten-3-yne moiety. This molecule features a triple bond at the third carbon of the buten-3-yne chain, which is attached to a cyclohexane ring at the fourth position. The compound is of interest in organic chemistry due to its potential applications in the synthesis of various pharmaceuticals and other chemical products. Its structure provides a platform for further functionalization and reactions, making it a versatile building block in the realm of organic synthesis.

2807-14-9

Post Buying Request

2807-14-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2807-14-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2807-14-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,0 and 7 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2807-14:
(6*2)+(5*8)+(4*0)+(3*7)+(2*1)+(1*4)=79
79 % 10 = 9
So 2807-14-9 is a valid CAS Registry Number.

2807-14-9Relevant academic research and scientific papers

Site-Selective and Stereoselective trans-Hydroboration of 1,3-Enynes Catalyzed by 1,4-Azaborine-Based Phosphine-Pd Complex

Xu, Senmiao,Zhang, Yuanzhe,Li, Bo,Liu, Shih-Yuan

, p. 14566 - 14569 (2016/11/18)

A concise synthesis of monobenzofused 1,4-azaborine phosphine ligands (Senphos) is described. These Senphos ligands uniquely support Pd-catalyzed trans-selective hydroboration of terminal and internal 1,3-enynes to furnish corresponding dienylboronates in

Synthesis of exo-3-ammo-7-azabicyclo[2.2.1]heptanes as a class of malarial aspartic protease inhibitors: Exploration of two binding pockets

Zuercher, Martina,Hof, Fraser,Barandun, Luzi,Schuetz, Andri,Schweizer, W. Bernd,Meyer, Solange,Bur, Daniel,Diederich, Francois

supporting information; experimental part, p. 1707 - 1719 (2009/08/09)

The increasing prevalence of drug-resisLant strains of malaria-causing Plasmodium parasites necessitates the development of therapeutic agents that inhibit new biochemical targets. We herein describe the design, synthesis, and in vitro evaluation of a class of inhibitors that target the malarial aspartic proteases known as the plasmepsins. The title compounds feature a 7-azanorbornane skeleton that bears an exo-amino function, which was designed to interact with the catalytic dyad of aspartic proteases while providing vectors for the attachment of binding elements that target the flap and S1/S3 binding pockets at. the enzyme active site. Their synthesis takes advantage of a solvent-free and highly diastereoselective conjugate addition of amines to bicyclic vinyl sulfones. Structural optimization based on a little-known conformational preference of aryl sulfones produced the most potent inhibitors of this new class. In vitro assays demonstrate that the title compounds are capable of potent (IC50 ≥ 1.0 nM) inhibition of plasmepsins, while remaining relatively weak inhibitors of the closely related human enzymes cathepsins D and E. The ideal occupation of the flap pocket is crucial for both potency and selectivity over the human proteases. Differently functionalized compounds were synthesized to gain new insights info the molecular recognition properties of this cavity. Wiley-VCH Verlag GmbH & Co. KGaA.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2807-14-9